ENTA—In all seriousness, 95% SVR12 from 8w Tx is probably not good enough in GT3 patients w/o cirrhosis; let's see how the 12w arm from ENDURANCE-3 looks when those data are presented.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”